Absence of Severe Complications From SARS-CoV-2 Infection in Children With Rheumatic Diseases Treated With Biologic Drugs
Giovanni Filocamo, Francesca Minoia, Simone Carbogno, Stefania Costi, Micol Romano, Rolando Cimaz
Abstract
We read with interest the editorial by Cron and Chatham 1 suggesting a cytokine storm syndrome (CSS) occurring in response to SARS-CoV-2 infection and, consequently, a possible role for targeted approaches to blocking inflammatory cytokines.
Topics & Concepts
MedicineAsymptomaticPediatric intensive care unitCytokine stormIntensive care unitPediatricsCohortSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Severity of illnessTocilizumabInternal medicineCoronavirus disease 2019 (COVID-19)Intensive care medicineImmunologyDiseaseInfectious disease (medical specialty)COVID-19 Clinical Research StudiesLong-Term Effects of COVID-19Inflammasome and immune disorders